Clinical Trial Update: Transdermally Delivered Human Insulin Product

View source ↗

Summary

A completed clinical trial evaluating a transdermally delivered human insulin product for hypoinsulinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoinsulinemia

Drugs mentioned

• Transdermal insulin product (insulin (transdermal delivery))

Snippet

Sponsor: Transdermal Delivery Solutions Corp | Conditions: Hypoinsulinemia | Status: COMPLETED